Privigen 10% vial 400ML
Ended Awarded
- Contract number
- SPE2DB25FKELE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,816
Award facts
- Contract value 100% obligated
- $69,816.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $69,816 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of PRIVIGEN 10% Vial 400ML. The contract, issued September 2, 2025, with an ultimate completion date of September 23, 2025, carries no set-aside designation. PRIVIGEN is an intravenous immunoglobulin (IVIG) product used for immunodeficiency disorders and other immune-related conditions, representing a critical pharmaceutical supply for military and federal healthcare facilities. The delivery will be fulfilled at the vendor's location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. This master contract vehicle enables DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare sites worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively across an extensive portfolio of medical product categories serving military health facilities.
Quick answers
Who was awarded contract SPE2DB25FKELE?
SPE2DB25FKELE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FKELE worth?
The government has obligated $69,816 on SPE2DB25FKELE.
Is contract SPE2DB25FKELE an order under another contract?
Yes. SPE2DB25FKELE is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKELE competed?
The extent of competition for SPE2DB25FKELE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award